Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and Virginijus Šikšnys . The company has partnerships with Novartis and Regeneron. Intellia Therapeutics was founded in May 2014 to develop biopharmaceuticals using CRISPR.

Exchange

NASDAQ/NMS (GLOBAL MARKET)

Sector

Manufacturing

CEO

John Leonard

Employees

211

Address

40 Erie St Ste 130

Cambridge, Massachusetts, 02139-4254

Website

http://www.intelliatx.com/

Industry

Pharmaceutical Preparation Manufacturing

Top Streaming News